These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28397841)

  • 41. Targeting glutamate signalling in depression: progress and prospects.
    Murrough JW; Abdallah CG; Mathew SJ
    Nat Rev Drug Discov; 2017 Jul; 16(7):472-486. PubMed ID: 28303025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.
    DeLorenzo C; Milak MS; Brennan KG; Kumar JS; Mann JJ; Parsey RV
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1083-94. PubMed ID: 21279350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone.
    Zimmer ER; Parent MJ; Leuzy A; Aliaga A; Aliaga A; Moquin L; Schirrmacher ES; Soucy JP; Skelin I; Gratton A; Gauthier S; Rosa-Neto P
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1169-74. PubMed ID: 25806702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.
    Milak MS; Rashid R; Dong Z; Kegeles LS; Grunebaum MF; Ogden RT; Lin X; Mulhern ST; Suckow RF; Cooper TB; Keilp JG; Mao X; Shungu DC; Mann JJ
    JAMA Netw Open; 2020 Aug; 3(8):e2013211. PubMed ID: 32785636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
    Hashimoto K
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.
    Valentine GW; Mason GF; Gomez R; Fasula M; Watzl J; Pittman B; Krystal JH; Sanacora G
    Psychiatry Res; 2011 Feb; 191(2):122-7. PubMed ID: 21232924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex differences in [
    Smart K; Cox SML; Scala SG; Tippler M; Jaworska N; Boivin M; Séguin JR; Benkelfat C; Leyton M
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1179-1183. PubMed ID: 30627817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder.
    Akkus F; Mihov Y; Treyer V; Ametamey SM; Johayem A; Senn S; Rösner S; Buck A; Hasler G
    Transl Psychiatry; 2018 Jan; 8(1):17. PubMed ID: 29317611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.
    Milella MS; Marengo L; Larcher K; Fotros A; Dagher A; Rosa-Neto P; Benkelfat C; Leyton M
    Neuroimage; 2014 Sep; 98():195-202. PubMed ID: 24795154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography.
    Akkus F; Ametamey SM; Treyer V; Burger C; Johayem A; Umbricht D; Gomez Mancilla B; Sovago J; Buck A; Hasler G
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):737-42. PubMed ID: 23248277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine.
    Elmeseiny OSA; Müller HK
    Pharmacol Res; 2024 Feb; 200():107081. PubMed ID: 38278430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators.
    Isherwood SN; Robbins TW; Dalley JW; Pekcec A
    J Neurochem; 2018 Apr; 145(2):111-124. PubMed ID: 29315577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.
    Nugent AC; Ballard ED; Gould TD; Park LT; Moaddel R; Brutsche NE; Zarate CA
    Mol Psychiatry; 2019 Jul; 24(7):1040-1052. PubMed ID: 29487402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ketamine and other potential glutamate antidepressants.
    Dutta A; McKie S; Deakin JFW
    Psychiatry Res; 2015 Jan; 225(1-2):1-13. PubMed ID: 25467702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.
    Abdallah CG; Adams TG; Kelmendi B; Esterlis I; Sanacora G; Krystal JH
    Depress Anxiety; 2016 Aug; 33(8):689-97. PubMed ID: 27062302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model.
    Choi H; Kim YK; Oh SW; Im HJ; Hwang DW; Kang H; Lee B; Lee YS; Jeong JM; Kim EE; Chung JK; Lee DS
    PLoS One; 2014; 9(3):e92765. PubMed ID: 24663806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imaging the effect of ketamine on synaptic density (SV2A) in the living brain.
    Holmes SE; Finnema SJ; Naganawa M; DellaGioia N; Holden D; Fowles K; Davis M; Ropchan J; Emory P; Ye Y; Nabulsi N; Matuskey D; Angarita GA; Pietrzak RH; Duman RS; Sanacora G; Krystal JH; Carson RE; Esterlis I
    Mol Psychiatry; 2022 Apr; 27(4):2273-2281. PubMed ID: 35165397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Imaging of mGluR5 Availability with [
    Kosten L; Deleye S; Stroobants S; Wyffels L; Mingote S; Rayport S; Staelens S
    Cell Mol Neurobiol; 2019 Mar; 39(2):255-263. PubMed ID: 30552621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors.
    Lazarevic V; Yang Y; Flais I; Svenningsson P
    Mol Psychiatry; 2021 Dec; 26(12):7425-7435. PubMed ID: 34376822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.